December 2016 FDA Recall Drug by Teva Pharmaceuticals Usa
D-0440-2017 - Subpotency

This Class II drug recall was voluntarily initiated by Teva Pharmaceuticals Usa on December 21, 2016 for the product Drug. The FDA reported the reason for recall as subpotency. The product was distributed in United States and Puerto Rico and the recall is currently terminated.

Recall Number: D-0440-2017

Reason for Recall
Subpotency: due to a low, out of specification test result for assay during stability testing.
Initiated
12-21-2016
Reported
02-01-2017
Quantity
133,601 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Teva Pharmaceuticals USA
United States and Puerto Rico
Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in a 100 mL bottle, Rx only, Manufactured for: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-4150-73

Batch or Lot Expiration Information

Lot# 35432507A, 35434914A, 35435798A, 35437490A, Exp 9/19